Licoforte

Quick links to important sections

Licoforte

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Licoforte

Quick Facts

Property Description
Active Ingredient Hydroquinone (INN)
Form Topical Gel
Pharmacological Class Topical Depigmenting Agent
General Purpose To lighten hyperpigmented skin areas
Origin Synthetic Aromatic Organic Compound

What Type of Medicine is Licoforte?

Licoforte is a prescription-only medicinal product classified as a topical depigmenting agent, formulated specifically as a gel for external use on the skin. This pharmaceutical preparation is designed to address issues of excessive pigmentation, offering a controlled approach to managing skin discoloration. Its primary mode of application is cutaneous (topical), a form recognized for local drug delivery in dermatology. The gel dosage form is a key feature, often providing a lighter, less occlusive base than creams, which facilitates efficient absorption of the active substance into the target skin layers.


What is Licoforte Gel Made Of?

The sole active ingredient in Licoforte is Hydroquinone (INN), a synthetic aromatic organic compound widely studied and clinically recognized for its dermatological use. Hydroquinone, formally known as 1,4-dihydroxybenzene, is chemically classified as an organic compound. The active compound is integrated into a specialized hydroalcoholic vehicle, which assists in the stability and effective delivery of the active substance. This formulation includes necessary non-active components such as the antioxidants Sodium Metabisulfite and Butylhydroxytoluene to maintain the stability of the active ingredient, a factor crucial for preserving its efficacy.


What is the General Purpose of a Topical Depigmenting Agent?

The general purpose of Licoforte is to achieve a gradual lightening of hyperpigmented skin by interrupting the biochemical process responsible for creating dark spots. As a topical depigmenting agent, the drug's fundamental function is to promote a gradual reduction of excess melanin production. Hydroquinone achieves this by inhibiting the tyrosinase enzyme, which is essential for melanin synthesis. This mechanism ensures the product is intended to help relieve or diminish the appearance of persistent dark spots on the skin.

What side effects are possible with Licoforte?

Possible side effects and safety information

Regulatory safety documents classify the majority of adverse reactions associated with Licoforte (hydroquinone) as localized dermatological reactions. These are often described as common or occasional effects and include mild burning, stinging, itching (pruritus), and redness (erythema) of the treated skin. The product's safety profile focuses on distinguishing these expected local reactions from rare, more serious events, primarily affecting the Skin and Subcutaneous Tissue Disorders and the Immune System Disorders.


Serious Adverse Reactions and Key Safety Constraints

Official labeling highlights the risk of Exogenous Ochronosis, a serious adverse reaction defined as a gradual, progressive blue-black darkening or discoloration of the skin. This effect is documented to be associated with prolonged use of hydroquinone and is officially noted to occur predominantly in certain racial or ethnic groups. Hypersensitivity reactions are also listed, including localized contact dermatitis and, potentially, severe allergic-type responses such as anaphylactic symptoms which can be linked to the preservative Sodium Metabisulfite [FDA].


Population-Specific Safety

The regulatory profile addresses specific patient populations. The safety and effectiveness of the medication have not been established for patients under the age of 12 years [DailyMed]. Furthermore, the medication is classified as Pregnancy Category C, and regulatory documents state that it is unknown whether hydroquinone is excreted in human milk [DailyMed]. Sun exposure must be strictly minimized, as mandated by the regulatory context, to prevent the re-occurrence of hyperpigmentation and reduce the potential for photosensitivity.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory guidance on Licoforte (Hydroquinone topical gel) addresses overdose risks primarily through accidental ingestion and severe topical reactions.

Documented Overdose Manifestations

Category Manifestations Documented in Official Labeling
Local Acute Misuse Severe skin reactions, including blistering, oozing, severe stinging or burning, cracking, and intense redness.
Accidental Ingestion Systemic toxicity signs such as cyanosis, dyspnea (labored breathing), convulsions, vomiting, and collapse.
Chronic Toxicity Exogenous ochronosis, a severe, documented outcome appearing as a blue-black darkening of the skin, which requires product discontinuation.

Required Emergency Actions

The most critical action mandated by regulatory documents is to seek immediate emergency medical attention or contact a Poison Control Center (or equivalent national service) immediately if the medication is accidentally swallowed, even if no severe symptoms are initially apparent. Urgent medical help is also required for signs of a severe allergic reaction, such as swelling of the face, difficult breathing, or life-threatening asthmatic episodes (often associated with the sulfite excipient).

Treatment for systemic overdose is defined as symptomatic and supportive, as official labeling indicates that no specific antidote is known. The safety and efficacy have not been established for children 12 years and under.

Therapeutic Uses of Licoforte

Quick Facts: Uses of Licoforte

Condition Therapeutic Domain
Melasma Helps reduce the appearance of darkened patches
Freckles May assist in lightening areas of skin pigmentation
Age Spots (Senile Lentigines) Used as part of a regimen to address skin discoloration
Chloasma Intended for the gradual reduction of hyperpigmented areas

What Licoforte Treats: Main Uses and Benefits

Licoforte (containing hydroquinone) is a prescription medication used topically to gradually lighten areas of darkened skin that result from various forms of hyperpigmentation. This treatment is generally included in a comprehensive skin care regimen to address specific discolorations.

It is indicated for managing conditions where the skin has developed unwanted areas of excess melanin, which appears as brown or gray-brown patches. These include melasma, often referred to as the 'mask of pregnancy,' which typically appears on the face. Licoforte may also be utilized to help reduce the appearance of freckles and age spots (senile lentigines).

The goal of therapy is to support the reduction of these pigmented areas, leading to a more uniform skin tone. Due to the potential for repigmentation, sun avoidance and the use of effective sunscreen are considered an essential component of the treatment regimen.

Licoforte is intended for use under the direction of a healthcare provider and should be used exactly as prescribed to support desired outcomes and avoid potential adverse effects.

Eligibility and Restrictions for Use

Eligibility and Contraindications for Licoforte

Licoforte (topical hydroquinone) is subject to specific population eligibility rules defined by regulatory authorities. These rules determine who may use the medicine under standard conditions and who is restricted or contraindicated from use.


Contraindicated Populations

Licoforte is contraindicated and must not be used by individuals with a prior history of hypersensitivity or allergic reaction to hydroquinone or to any other ingredient in the product. This specifically includes patients with known allergies to components such as sodium metabisulfite.


Age-Related Restrictions

Use of Licoforte is not established in pediatric patients under the age of 12 years. The medicine is established for use in adults and adolescents aged 12 years and older who do not have any contraindications.


Conditional and Restricted Use

Use requires caution or is restricted in several populations:

  • Pregnancy: Classified as Pregnancy Category C. It should be used only if the potential benefit clearly justifies the potential risk.
  • Lactation: Caution is advised for nursing mothers, as it is not known whether the drug is excreted in human milk.
  • Comorbidities: Patients with asthma may have an increased susceptibility to allergic-type reactions from the sulfite preservative in the formulation, requiring special consideration.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Licoforte (hydroquinone topical gel) centers on local substance conflicts and additive dermatological risk, consistent with its minimal systemic absorption into the bloodstream. No systemic pharmacokinetic interactions, such as those involving CYP enzymes or drug transporters, are formally documented in prescribing information.

Documented Topical Interactions

Two main interaction categories are formally documented by government health authorities:

  • Local Chemical Reaction Risk: Simultaneous use of Licoforte with peroxide-containing topical products, such as Benzoyl Peroxide, results in a local chemical oxidation reaction. This reaction manifests as temporary brown or black staining on the skin. This effect mandates a timing-based restriction, requiring that these products must not be applied to the same area at the same time.

  • Additive Pharmacodynamic Risk: Caution is formally advised on the concomitant use of photosensitizing drugs (e.g., certain antimalarial agents or phenol derivatives). This interaction is based on an additive effect that increases the potential for developing exogenous ochronosis, a specific type of blue-black skin hyperpigmentation.

Regulatory summaries further specify no formally known interactions with food, alcohol, or herbal supplements, solidifying the focus on localized topical constraints. The interaction structure is entirely based on these local restrictions and documented additive risk potential.

Mechanism of Action

How Licoforte Works

Licoforte Gel (Hydroquinone) operates through a targeted mechanism focused exclusively on the biological processes responsible for creating and distributing skin pigment. The mechanism results in a physiological effect centered on the reduction of pigment content.


Molecular Inhibition of Melanin Synthesis

The primary mechanism involves the direct and reversible inhibition of the enzyme Tyrosinase, which is the critical molecular target governing the speed of the melanogenesis pathway. By acting as a competitive inhibitor and an alternate substrate, Hydroquinone fundamentally slows the chemical synthesis of new pigment (melanin) within the melanocytes. This suppression of new pigment production forms the molecular basis for the downstream effect on pigment content.


Modulation of Pigment Distribution and Cellular Kinetics

The drug also influences the behavior of melanocytes by interfering with the integrity and transfer of their pigment organelles, known as melanosomes. This mechanism accelerates the degradation of the melanosomes and significantly inhibits their transfer to surrounding keratinocytes. This interference with pigment distribution, combined with the normal epidermal turnover cycle, contributes to the physiological turnover of older, pigmented cells, which are replaced by cells containing less pigment.

Dosage and Administration Information

Official Administration Guidelines for Licoforte

Licoforte is administered topically and is intended strictly for external cutaneous use. The preparation is typically available as a 4% concentration gel, which is applied directly to the skin.

Labeled Dosing and Administration

The standard administration schedule involves applying a thin film of the gel to the specific hyperpigmented areas. This application is generally performed twice daily, once in the morning and once again before bedtime. It is procedurally necessary that the preparation be rubbed into the skin well until it is absorbed.

Prior to initiating the full course of therapy, it is recommended to perform a small skin sensitivity test by applying a minimal amount of the gel to an unbroken skin area and observing the site over 24 hours.

Duration and Special Conditions

A specific assessment period is required: treatment should be discontinued if no satisfactory gradual lightening of the skin is observed after two months of consistent use.

A crucial condition for the proper use of Licoforte is the daily application of a broad-spectrum sunscreen (SPF 15 or greater) or the use of protective clothing on all treated areas. This environmental management is integral to the administration protocol. Furthermore, the safety and effectiveness of this preparation have not been established for patients under 12 years of age.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Licoforte


Evidence from Clinical Trials for Melasma

The research base for Licoforte primarily examined melasma, a skin condition characterized by darkened patches often appearing on the face. The main types of research informing its use are Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies primarily focused on adult women, as this demographic is most often affected by melasma. Research examined the condition over short-term periods, typically lasting between 8 and 12 weeks.

To assess how symptoms changed during the study period, researchers monitored outcomes using objective clinical scoring tools, such as the Melasma Area and Severity Index (MASI). Findings describe patterns observed in the studies related to measured changes in pigmentation. Evidence is limited for outcomes when Licoforte is used alone (monotherapy), as the findings often relate to the medicine used as part of a triple-combination regimen.


Evidence for Other Types of Hyperpigmentation

Licoforte was also evaluated in research exploring other conditions, including age spots (solar lentigines), freckles, and Post-inflammatory Hyperpigmentation (PIH). These studies, which include Comparative Studies, often explored short-term symptom changes over periods up to 16 weeks. Researchers utilized instrumental assessments to track changes in the darkness of these spots.

Research so far describes that the observed patterns of change are mainly associated with pigmentation located in the superficial layers of the skin (epidermis). Data show patterns related to lower levels of change in pigmentation located in the deeper skin layer (dermis). For these conditions, evidence quality varies across studies.


Research Gaps and Areas of Uncertainty

The research explored whether the patterns of pigmentation change observed during the initial study period persisted in post-study intervals. The available follow-up durations were generally limited, meaning long-term effects are not fully established. One key area of uncertainty is the data for the medicine used as a monotherapy, and research comparing the medicine against certain alternative treatments remains limited.

Frequently Asked Questions (FAQ)

Common questions about Licoforte (FAQ)


Q: How long does it usually take to notice any effect from Licoforte?

A: Studies and official information indicate that observed changes in pigmentation have been described as early as four weeks of use. Official administration instructions note that regulatory protocol requires an assessment of use after two months (8 weeks) if no satisfactory gradual lightening is seen.


Q: Is Licoforte known to cause weight gain?

A: According to the official product information, the majority of documented adverse reactions for this medicine are localized effects on the skin. Weight gain is not described as a common or serious adverse reaction in the patient information for this single-ingredient topical formulation.


Q: Does Licoforte cause dry mouth?

A: The official product safety profile describes localized dermatological effects as the most common adverse reactions. Dry mouth is not listed or described as a common or serious adverse reaction for this topical medicine in the regulatory documents.


Q: Is it normal to feel tired or fatigued when starting Licoforte?

A: Official documents describe the majority of adverse reactions as localized dermatological effects. Systemic effects such as fatigue or tiredness are not described as common or serious adverse reactions in the official patient information for this topical formulation.


Q: What should I know about Licoforte's potential effects on driving or operating machinery?

A: Licoforte is formulated for local skin use, resulting in minimal systemic absorption into the bloodstream. Because of this, official patient information does not contain specific warnings or precautions regarding the ability to drive or operate machinery.


Q: Is Licoforte safe to use during pregnancy (as described in official sources)?

A: Regulatory documents classify the medicine as Pregnancy Category C. This status indicates that use during pregnancy is conditional upon the potential benefit justifying the potential risk.


Q: Is Licoforte safe to take with birth control pills?

A: The official regulatory profile for Licoforte is focused on local topical interactions. No systemic pharmacokinetic interactions with other medicines taken by mouth, such as oral contraceptives (birth control pills), are formally documented in the prescribing information.


Q: Can Licoforte be crushed or split if the original form is a tablet?

A: Licoforte is a topical gel intended for external application directly on the skin. It is not formulated as a tablet or capsule, and therefore the question of crushing or splitting does not apply.


Q: Are there any specific foods or drinks to avoid while using Licoforte?

A: Regulatory documents state there are no formally known interactions between Licoforte and food or drinks. The drug’s interaction profile is focused on localized constraints where it is applied topically.


Q: Does Licoforte interact with grapefruit or grapefruit juice?

A: The official regulatory profile states that there are no formally known interactions with food, which includes grapefruit or grapefruit juice. The risk of interaction with this product is centered on topical agents applied to the same area.


Q: Can I take Licoforte if I am lactose intolerant?

A: The non-active ingredients listed in the formulation include a hydroalcoholic vehicle, Sodium Metabisulfite, and Butylhydroxytoluene. Official documents do not list lactose as an ingredient in the product formulation.


Q: What is the risk of dependence or addiction with Licoforte?

A: Licoforte is not classified as a controlled substance by regulatory bodies. The official documents for this topical medicine do not describe any risk of physical dependence or addiction with its use.


Q: Can Licoforte cause changes in mood or behavior?

A: Official documents describe the majority of adverse reactions as localized dermatological effects. Systemic effects like changes in mood or behavior are not described as common or serious adverse reactions for this topical formulation.


Q: What is Licoforte's half-life or how quickly is it cleared from the body (simple answer)?

A: Regulatory documents state that the medicine is minimally absorbed into the bloodstream. Because of this, specific values for half-life or clearance time are not formally documented in the product's prescribing information.


Q: Does official information restrict Licoforte use for people with liver problems?

A: The official contraindications and precautions listed in regulatory documents focus on hypersensitivity, age restrictions, and asthma due to a sulfite preservative. Pre-existing liver conditions are not listed as formal restrictions or cautions for this topical formulation.


Q: Does official information restrict Licoforte use for people with kidney disease?

A: The official contraindications and precautions listed in regulatory documents focus on hypersensitivity, age restrictions, and asthma due to a sulfite preservative. Pre-existing kidney conditions are not listed as formal restrictions or cautions for this topical formulation.


Q: Is Licoforte available over the counter?

A: Licoforte is officially classified as a prescription-only medicinal product. Furthermore, regulatory agencies have determined that hydroquinone-containing skin bleaching drug products are not approved for over-the-counter sale.


Q: Is Licoforte linked to hair loss?

A: Hair loss (alopecia) is not described as a common or serious adverse reaction in the official patient information for this topical formulation.


Q: Do official documents mention any effects of Licoforte on blood pressure?

A: The medicine is formulated for local skin use with minimal systemic absorption. For this reason, official documents do not mention any effects of Licoforte on blood pressure.


Q: Are there any known interactions between Licoforte and common vitamins?

A: The official regulatory profile focuses on local topical interactions and states there are no formally known interactions with food or herbal supplements. No specific interactions between Licoforte and common vitamins are documented in the prescribing information.

How should Licoforte be stored and disposed of?

The official labeling for Licoforte (Hydroquinone topical gel) specifies precise conditions for storage and disposal to maintain product integrity and ensure safety.

Storage Conditions

Licoforte must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed when not in use. It is mandatory to protect the product from direct sunlight and excessive heat; the medicine must not be frozen.

As a crucial safety requirement, Licoforte must be stored out of the reach of children.

Disposal Instructions

Unused or expired gel must be disposed of according to local regulations. If a drug take-back program is unavailable, the product should be mixed with an undesirable substance (such as dirt) in a sealed container before being discarded with household trash. The medication should not be flushed down a toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Licoforte found in:

A-Z Index: